Statins increase calcium buildup in arteries while lowering the risk of heart attacks and strokes by making atherosclerotic plaques more stable.
See the scientific wording
Statin use increases arterial calcification and reduces cardiovascular events through the stabilization of atherosclerotic plaques.
Correlational — new studies may shift this
Observational3 moderate-quality studies link this claim to the outcome, but causation is not established.
What the research says
3 studies reviewedSupporting (3)
Cross-Sectional StudyHuman
Statins make artery plaques harder and more calcified, which makes them less likely to rupture and cause heart attacks — this study shows people taking statins have more of these stable, calcium-rich plaques and fewer soft, dangerous ones.
Case-Control StudyHuman2026
Statins can make calcium build up in certain parts of artery plaques, which actually helps make those plaques less likely to burst and cause heart attacks. This study shows that one statin, atorvastatin, does exactly that in key artery cells.
Coronary Artery Calcification: From Molecular Mechanisms to Interventional Strategies
Narrative ReviewReview2026
Statins make calcium build up in artery walls, but this type of buildup actually makes dangerous plaques more stable and less likely to break off and cause heart attacks or strokes.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Statins reduce cholesterol in artery walls, which changes the behavior of certain cells in the plaque. These cells start acting like bone cells, laying down hard calcium deposits that turn soft, dangerous plaques into stiff, stable ones. This prevents the plaques from bursting and causing heart attacks.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 3 supporting studies
Related videos
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Statins increase calcium buildup in arteries while lowering the risk of heart attacks and strokes by making atherosclerotic plaques more stable.
Mechanism
4 studiesStatins change artery wall cells to act like bone cells, which lay down hard calcium deposits that turn dangerous soft plaques into stable, rigid ones. This prevents the plaques from bursting and causing heart attacks, even though the arteries become more calcified.
Statins reduce cholesterol in artery walls, which changes the behavior of certain cells in the plaque. These cells start acting like bone cells, laying down hard calcium deposits that turn soft, dangerous plaques into stiff, stable ones. This prevents the plaques from bursting and causing heart attacks.
Statins inhibit HMG-CoA reductase, reducing intracellular mevalonate and isoprenoid intermediates
Reduced isoprenoid signaling alters Rho GTPase activity in vascular smooth muscle cells, triggering phenotypic switching from contractile to osteoblast-like state
Osteogenic transcription factors Runx2 and Osterix are upregulated, suppressing contractile proteins and activating bone matrix protein expression
Vascular smooth muscle cells and macrophages release matrix vesicles enriched with calcium, phosphate, phosphatidylserine, and annexins
Matrix vesicles nucleate hydroxyapatite crystals, which propagate into the extracellular matrix as dense, sheet-like calcifications
Hydroxyapatite deposition increases plaque stiffness, thickens the fibrous cap, and reduces lipid core expansion, preventing rupture
Less supported by current evidence, but not ruled out
In some cell types, statins block calcium buildup, but in others, they trigger it by changing how cells respond to the same drug, leading to localized calcification only in plaque-stabilizing regions.
Statins inhibit HMG-CoA reductase, reducing mevalonate pathway intermediates
In mesenchymal stromal cells, reduced isoprenoids suppress osteogenic transcription factors and inhibit mineralization
In smooth muscle-like cells, reduced isoprenoids dysregulate Rho GTPase signaling, promoting osteogenic transdifferentiation
Cell-type-specific responses result in calcification only in vascular smooth muscle-derived cells within the plaque cap
Statins increase an enzyme that breaks down a natural blocker of calcium buildup, allowing more calcium to form hard deposits in artery walls.
Statins increase alkaline phosphatase expression in vascular smooth muscle cells and circulating serum
Alkaline phosphatase hydrolyzes inorganic pyrophosphate, a potent inhibitor of hydroxyapatite formation
Reduced pyrophosphate concentration removes inhibition of calcium-phosphate crystallization
Uninhibited calcium and phosphate ions nucleate into hydroxyapatite crystals in the arterial wall
Evidence from Studies
Last searched 2mo ago
Supporting (3)
Community contributions welcome
Statins make artery plaques harder and more calcified, which makes them less likely to rupture and cause heart attacks — this study shows people taking statins have more of these stable, calcium-rich plaques and fewer soft, dangerous ones.
Differential effects of atorvastatin on calcification in stromal and vascular cells within monolayer and 3D plaque cap models.
Statins can make calcium build up in certain parts of artery plaques, which actually helps make those plaques less likely to burst and cause heart attacks. This study shows that one statin, atorvastatin, does exactly that in key artery cells.
Coronary Artery Calcification: From Molecular Mechanisms to Interventional Strategies
Statins make calcium build up in artery walls, but this type of buildup actually makes dangerous plaques more stable and less likely to break off and cause heart attacks or strokes.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Statin Therapy Effects on Arterial Calcification and Cardiovascular Event Rates in Adults
Population: Adults with atherosclerosis or at high cardiovascular risk; Intervention: Statin therapy at standard clinical doses; Comparator: Placebo or no statin; Outcomes: Quantitative change in arterial calcification (e.g., Agatston score) and incidence of myocardial infarction, stroke, or cardiovascular death; Duration: Minimum 5 years of follow-up.
Double-Blind RCT of Rosuvastatin vs Placebo on Coronary Calcification Progression and Major Cardiovascular Events
Population: 5,000 adults aged 50–75 with subclinical atherosclerosis; Intervention: Rosuvastatin 20 mg daily; Comparator: Placebo; Outcomes: Change in coronary artery calcium score and composite cardiovascular events (MI, stroke, CV death); Duration: 4 years.
Prospective Cohort Study of Statin Use, Coronary Calcification, and Cardiovascular Outcomes in a General Population
Population: 10,000 adults without cardiovascular disease at baseline; Intervention: Self-reported or pharmacy-recorded statin use; Comparator: Non-users; Outcomes: Annual CT imaging of coronary calcium and adjudicated cardiovascular events over 10 years; Confounders adjusted for age, lipid levels, smoking, diabetes.
In Vitro Analysis of Statin Effects on Vascular Smooth Muscle Cell Calcification and Plaque Stability Markers
Population: Human vascular smooth muscle cells and macrophages derived from arterial tissue; Intervention: Exposure to atorvastatin at therapeutic concentrations; Comparator: Untreated cells; Outcomes: Calcium deposition, expression of osteogenic markers (Runx2, BMP2), and plaque stability proteins (MMP-9, TIMP-1); Duration: 7–14 days.
ApoE−/− Mouse Model Study of Statin Effects on Aortic Calcification and Plaque Composition
Population: ApoE−/− mice fed high-fat diet; Intervention: Atorvastatin in diet (equivalent to human therapeutic dose); Comparator: High-fat diet without statin; Outcomes: Aortic calcification (micro-CT), plaque size, collagen content, macrophage infiltration; Duration: 12 weeks.